Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 250-254

  Byington, Carrie L ^a,d   Korgenski, Kent ^b   Daly, Judy ^b   Ampofo, Krow ^a   Pavia, Andrew ^a   Mason, Edward O ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Empyema; Immunization; Streptococcus pneumoniae

Indexed keywords

HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; EMPYEMA; FEMALE; HUMAN; IMMUNIZATION; INTENSIVE CARE; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PARAPNEUMONIC EMPYEMA; PEDIATRICS; PENICILLIN RESISTANCE; PLEURA FLUID; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; UNITED STATES;

CHILD, PRESCHOOL; EMPYEMA, PLEURAL; FEMALE; HUMANS; IMMUNIZATION; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, BACTERIAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UTAH; VACCINES, CONJUGATE;

EID: 33644920167     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202137.37642.ab     Document Type: Article

References (24)

1. Freij BJ, Kusmiesz H, Nelson JD, McCracken GH Jr. Parapneumonic effusions and empyema in hospitalized children: a retrospective review of 227 cases. Pediatr Infect Dis. 1984;3:578-591.
2. Chonmaitree T, Powell KR. Parapneumonic pleural effusion and empyema in children: review of a 19-year experience, 1962-1980. Clin Pediatr (Phila). 1983;22:414-419.
3. Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CD. Pneumococcal pleural empyemas in children. Clin Infect Dis. 1996;22:1057-1063.
4. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434-440.
5. Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110(1, pt 1):1-6.
6. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522-525.
7. Rees JH, Spencer DA, Parikh D, Weller P. Increase in incidence of childhood empyema in West Midlands, U.K. Lancet. 1997;349:402.
8. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005;41:21-29.
9. American Academy of Pediatrics Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of the pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccheride vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
10. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
11. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113(3, pt 1):443-449.
12. Clinical and Laboratory Standards Institute. Standard Methods for Dilution Antimicrobial Tests for Bacteria that Grow Aerobically, M7-A5. Villanova, PA: Clinical and Laboratory Standards Institute; 2000.
13. Feola GP, Shaw LC, Coburn L. Management of complicated parapneumonic effusions in children. Tech Vasc Interv Radiol. Dec. 2003;6:197-204.
14. Hawkins JA, Scaife ES, Hillman ND, Feola GP. Current treatment of pediatric empyema. Semin Thorac Cardiovasc Surg. Fall. 2004;16:196-200.
15. Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet. 2001;357:950-952.
16. Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002;35:547-555.
17. Finland M. The significance of pneumococcus types in disease, including types IV-XXXII (Cooper). Ann Intern Med. 1937;10:1531-1543.
18. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 2003;41:521-522.
19. Saglani S, Harris KA, Wallis C, Hartley JC. Empyema: the use of broad range 16S rDNA PCR for pathogen detection. Arch Dis Child. 2005;90: 70-73.
20. Long SS. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine. Clin Infect Dis. 2005;41:30-34.
21. McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40:1738-1744.
22. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203-1211.
23. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A. 1997;94:6571-6576.
24. Samore M, Alder S, Haddadin B, et al. Effect of heptavalent pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance on carriage pneumococcal isolates from healthy children in rural communities. Paper presented at: 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, October 30-November 2, 2004, Washington, DC. Washington, DC: American Society for Microbiology; 2004.